Humacyte, Inc. (HUMA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Humacyte, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.72x | -4.02x | -2.65x | -18.17x | -10.94x | -1.90x |
| P/B Ratio | 48.86x | -11.36x | 21.68x | 1.86x | 2.37x | 1.79x |
| P/S Ratio | 74.54x | 0.00x | 0.00x | 138.94x | 229.44x | 84.91x |
| Profitability | ||||||
| Gross Margin | -736.5% | 0.0% | 0.0% | -427.5% | -4756.8% | -3527.0% |
| Operating Margin | -5271.7% | 0.0% | 0.0% | -5404.3% | -6429.8% | -4332.7% |
| Net Margin | -2003.6% | 0.0% | 0.0% | -764.5% | -2096.4% | -4461.7% |
| EBITDA Margin | -4911.3% | 0.0% | 0.0% | -4879.7% | -5777.3% | -3772.6% |
| Liquidity | ||||||
| Current Ratio | 3.69x | 2.40x | 4.52x | 7.88x | 20.75x | 3.69x |
| Quick Ratio | 2.95x | 2.40x | 4.52x | 7.88x | 20.75x | 3.69x |
| Leverage | ||||||
| Debt/Equity | 20.86x | -0.31x | 4.24x | 0.43x | 0.42x | 0.41x |
YoY = year-over-year change. Source: FMP..